肠嗜铬样细胞增生评估有助于对幽门螺杆菌阴性萎缩性胃炎患者进行分类
该研究回顾184例组织学诊断为萎缩性胃炎且无幽门螺杆菌感染证据的患者,用神经内分泌免疫组化将肠嗜铬样细胞增生分为完全型、局灶型和无增生三组。三组在质子泵抑制剂使用、性别、微细胞性贫血和肠化生方面存在差异。
要点
- 完全型肠嗜铬样细胞增生者自身抗体阳性率73%,且仅该组发生胃神经内分泌肿瘤。
- 完全型组平均胃泌素水平700 pg/mL,显著高于无增生组。
- 局灶型组质子泵抑制剂使用率64%,显著高于完全型组。
核心结论
- 基于肠嗜铬样细胞增生程度的分层虽非萎缩性胃炎诊断必需,但可区分出临床和病理特征显著不同的患者组。
研究设计与样本
- 回顾性研究,纳入184例组织学诊断为萎缩性胃炎且无幽门螺杆菌感染证据的患者,根据神经内分泌免疫组化标记将肠嗜铬样细胞增生分为完全型、局灶型和无增生三组。
临床怎么用
- 对幽门螺杆菌阴性萎缩性胃炎患者,神经内分泌免疫组化评估肠嗜铬样细胞增生程度可辅助识别自身免疫相关亚组及神经内分泌肿瘤高风险者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Atrophic gastritis (AG) is characterized by atrophy of gastric glands-in particular, oxyntic glands-in the setting of chronic inflammation; it is often autoimmune. The diagnosis is confirmed by immunohistochemistry (IHC) for gastrin (to confirm biopsy site), and pathologists often use IHC for neuroendocrine markers to evaluate for enterochromaffin-like cell hyperplasia (ECL-H). The utility of neuroendocrine staining is unclear, and we undertook this study to determine whether ECL pattern provided any additional information in cases of Helicobacter-negative AG. METHODS: We reviewed clinicopathologic findings in 184 cases from 184 patients with histologic AG and no evidence of Helicobacter infection. Using neuroendocrine IHC markers, cases were divided into 3 groups: Group 1 showed complete ECL-H (both qualitative and quantitative criteria met), group 2 showed focal ECL-H (qualitative but not quantitative criteria met), and group 3 showed no ECL-H (neither criteria met). RESULTS: Group 1 patients were more likely to have positive autoantibody serologies (73%, P = .0007 vs group 2) and higher mean gastrin levels (700 pg/mL, P = .017 vs group 3), and only these patients developed gastric neuroendocrine tumors. Group 2 patients were more likely to take proton pump inhibitors (64%, P = .0002 vs group 1). Group 3 patients were more likely to be male (70%, P = .008 vs group 1) and to have microcytic anemia (44%, P = .022 vs group 2) and less likely to have intestinal metaplasia (50%, P = .044 vs group 1). CONCLUSIONS: Stratification based on degree of ECL-H is not necessary for diagnosis of AG but does lead to statistically significant clinical and pathologic differences among groups.
引用
- Chen F, Gonzalez RS. Evaluation of enterochromaffin-like cell hyperplasia can help categorize patients with Helicobacter-negative atrophic gastritis. Am J Clin Pathol. 2025. PMID: 39724194. doi:10.1093/ajcp/aqae159
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。